Showing results (11-20 of 715) with videos related to
Sort By:
Pageof 72
Plos Pathogens|November 2, 2018
HIV control: Is getting there the same as staying there?Philip Goulder, Steven G DeeksCurrent HIV/AIDS Reports|April 29, 2010
When to start antiretroviral therapyVivek Jain, Steven G DeeksThe Journal of Infectious Diseases|July 3, 2019
Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A SymposiumNir Eyal, Steven G DeeksThe Journal of Infectious Diseases|August 29, 2024
Galectin 9 Levels as a Potential Predictor of Intact HIV Reservoir DecaySergio Serrano-Villar, Akshay Gala, Peter Bacchetti, et al.Current Opinion in Infectious Diseases|October 27, 2023
The microbiome as a biomarker of anal precancerous lesions in people with HIVRaquel Ron, Elena Moreno, Marta Rosas Cancio-Suárez, et al.Cell|September 26, 2024
Mechanisms of long COVID and the path toward therapeuticsMichael J Peluso, Steven G DeeksThe Journal of Infectious Diseases|July 3, 2019
How Unavoidable Are Analytical Treatment Interruptions in HIV Cure-Related Studies?David M Margolis, Steven G DeeksTrends in Immunology|May 18, 2017
Signature of the Sleeper Cell: A Biomarker of HIV Latency RevealedSatish K Pillai, Steven G DeeksScience Translational Medicine|July 15, 2011
Drug effectiveness explained: the mathematics of antiviral agents for HIVAlan S Perelson, Steven G DeeksCurrent Opinion in HIV and AIDS|April 18, 2009
Partial treatment interruptionsSteven G Deeks, Jeffrey N MartinPageof 72